Literature DB >> 17803831

Conduct disorder among Asians and Native Hawaiian/Pacific Islanders in the USA.

J T Sakai1, N K Risk, C A Tanaka, R K Price.   

Abstract

BACKGROUND: Conduct disorder (CD) is a relatively common disorder of childhood and adolescence in the USA with substantial associated morbidity, yet little has been published on CD among Asians and Native Hawaiian/Pacific Islanders (NH/PI) in the USA.
METHOD: We used the National Epidemiological Survey on Alcohol and Related Conditions (NESARC) to examine the prevalence and correlates of retrospectively reported CD within Asians and NH/PI (18 years and older). We also completed logistic regressions to explore factors associated with CD within Asians (n=1093) and, separately, NH/PI (n=139) and to explain racial differences in CD prevalence.
RESULTS: Asians were about a third as likely [odds ratio (OR) 0.4, 95% confidence interval (CI) 0.22-0.58] whereas NH/PI were about two and half times more likely (OR 2.6, 95% CI 1.31-5.06) to have had CD compared with Caucasian respondents. Within Asians and NH/PI, CD was strongly associated with adult antisocial behavior, substance use and affective disorders. Demographic factors, the age that subjects came to the USA, measures of family environment and family history could not explain the observed differences in prevalence of CD for NH/PI relative to Caucasians.
CONCLUSIONS: Asian and NH/PI youth with CD represent a subgroup of Asian youth at very high risk for a number of serious psychiatric disorders. Further investigation is needed to explain the high CD prevalence among NH/PI.

Entities:  

Mesh:

Year:  2007        PMID: 17803831     DOI: 10.1017/S0033291707001316

Source DB:  PubMed          Journal:  Psychol Med        ISSN: 0033-2917            Impact factor:   7.723


  7 in total

1.  Prevalence and correlates of probable adolescent mental health problems reported by parents in Vietnam.

Authors:  Ananda B Amstadter; Lisa Richardson; Alicia Meyer; Genelle Sawyer; Dean G Kilpatrick; Trinh Luong Tran; Lam Tu Trung; Nguyen Thanh Tam; Tran Tuan; La Thi Buoi; Tran Thu Ha; Tran Duc Thach; Mario Gaboury; Ron Acierno
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2009-12-13       Impact factor: 4.328

2.  Race/ethnic differences in exposure to traumatic events, development of post-traumatic stress disorder, and treatment-seeking for post-traumatic stress disorder in the United States.

Authors:  A L Roberts; S E Gilman; J Breslau; N Breslau; K C Koenen
Journal:  Psychol Med       Date:  2010-03-29       Impact factor: 7.723

3.  Substance use and dependence among Native Hawaiians, Other Pacific Islanders, and Asian ethnic groups in the United States: contrasting multiple-race and single-race prevalence rates from a national survey.

Authors:  Joseph T Sakai; Cynthia Wang; Rumi Kato Price
Journal:  J Ethn Subst Abuse       Date:  2010       Impact factor: 1.507

4.  More alike than different: health needs, services utilization, and outcomes of Asian American and Pacific Islander (AAPI) populations treated for substance use disorders.

Authors:  Elizabeth Evans; Jennifer Pierce; Libo Li; Richard Rawson; Yih-Ing Hser
Journal:  J Ethn Subst Abuse       Date:  2012       Impact factor: 1.507

Review 5.  The National Epidemiologic Survey on Alcohol and Related Conditions (NESARC) Waves 1 and 2: review and summary of findings.

Authors:  Deborah S Hasin; Bridget F Grant
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2015-07-26       Impact factor: 4.328

6.  Racial/ethnic differences in health-related quality of life among Hawaii adult population.

Authors:  Eunjung Lim; James Davis; Chathura Siriwardhana; Lovedhi Aggarwal; Allen Hixon; John J Chen
Journal:  Health Qual Life Outcomes       Date:  2020-12-09       Impact factor: 3.186

7.  Prevalence of DSM-5 mental disorders in a nationally representative sample of children in Taiwan: methodology and main findings.

Authors:  Yi-Lung Chen; Wei J Chen; Kuan-Chia Lin; Lih-Jong Shen; Susan Shur-Fen Gau
Journal:  Epidemiol Psychiatr Sci       Date:  2019-01-30       Impact factor: 6.892

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.